product Image
LED Linear Lamp (External SMPS)
Model Name
LUMIMICRO Series
Data
-
Manufacturer information
provider logo
VIVOZON Pharmaceutical

Specialty and generic drugs

Problem with product info?
Update request
Manufacturer
VIVOZON Pharmaceutical
Brand
-
SKU
45347
Product Name
LED Linear Lamp (External SMPS)
Model Name
LUMIMICRO Series
Size
-
Weight
-
Product Details


Lumimicro LED Linear Lamp (External SMPS) LUMIMICRO Series


Lumimicro LED Linear Lamp (External SMPS) LUMIMICRO Series 1


Lumimicro LED Linear Lamp (External SMPS) LUMIMICRO Series 2


Lumimicro LED Linear Lamp (External SMPS) LUMIMICRO Series 3


Lumimicro LED Linear Lamp (External SMPS) LUMIMICRO Series 4

VIVOZON Pharmaceutical
Specialty and generic drugs
A new formulation technology, innovative quality improving technology, developed at Vivozon (Co., Ltd.) Since before liberation, Vivozon led the way to save lives.We started from Gyeongseong Pharmaceutical in 1938, and pioneered the inadequate pharmaceutical industry, and now as a member of Inist, armed with an even more advanced facility and research members, we are leading the way to transform incurable diseases into cured diseases. Based on our long-standing new formulation development technology and quality improvement technology, Vivozon, with product competitiveness and differentiation secured, has strived to provide various specialized medicine and general medicine with an outstanding research staff and quality management. We have launched a new manufacturing method for local patents of new drugs, and are focusing our research on developing alcohol detoxifying medicine, senile dementia treatment medicine, adult disease medicines, etc.In addition, we are equipped with cutting-edge facilities and production facilities built according to KPMG standards, striving to achieve perfection with a mission to protect life, through all processes from ingredient input to shipment. Time and know-how do not disappear, but become accumulated.Vivozon’s 80-year-history will become the foundation to accelerate the 110-year-old era.
Inquiry